These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7792819)

  • 21. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
    Oberfield SE; Levine LS; Carey RM; Greig F; Ulick S; New MI
    J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid activity of 16beta-hydroxydehydroepiandrosterone and related steroids.
    Gomez-Sanchez C; Holland OB; Higgins JR; Mathieu R; Gruber GM; Milewich L; Kaplan NM
    J Lab Clin Med; 1976 Oct; 88(4):571-7. PubMed ID: 135037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension.
    Gómez-Sánchez EP; Fort CM; Gómez-Sánchez CE
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E482-4. PubMed ID: 2316642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension and the mineralocorticoid receptor in the brain.
    Gómez Sánchez EP
    Ann N Y Acad Sci; 1994 Nov; 746():415-7. PubMed ID: 7825903
    [No Abstract]   [Full Text] [Related]  

  • 25. Mineralocorticoid selectivity: molecular and cellular aspects.
    Farman N; Bocchi B
    Kidney Int; 2000 Apr; 57(4):1364-9. PubMed ID: 10760068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies.
    Pasquale PD; Stefano GD; Paterna S
    Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited forms of mineralocorticoid hypertension.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    Best Pract Res Clin Endocrinol Metab; 2015 Aug; 29(4):633-45. PubMed ID: 26303089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New aspects of mineralocorticoid hypertension.
    Mantero F; Armanini D; Biason A; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
    Horm Res; 1990; 34(3-4):175-80. PubMed ID: 2151775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When is cortisol a mineralocorticoid?
    Clore J; Schoolwerth A; Watlington CO
    Kidney Int; 1992 Dec; 42(6):1297-308. PubMed ID: 1474763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension.
    Takeda Y; Miyamori I; Yoneda T; Furukawa K; Inaba S; Takeda R; Mabuchi H
    Hypertension; 1997 Oct; 30(4):953-6. PubMed ID: 9336399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineralocorticoid hypertension in childhood.
    New MI; Levine LS
    Mayo Clin Proc; 1977 May; 52(5):323-8. PubMed ID: 323586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineralocorticoid and hypertensive effects of 19-nor-progesterone.
    Hall CE; Gomez-Sanchez CE; Hungerford S; Gomez-Sanchez EP
    Endocrinology; 1981 Oct; 109(4):1168-75. PubMed ID: 7285865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone and mineralocorticoid receptors in the cardiovascular system.
    Funder JW
    Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biology of mineralocorticoid metabolism.
    Fardella CE; Miller WL
    Annu Rev Nutr; 1996; 16():443-70. PubMed ID: 8839934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mineralocorticoid and SGK1-sensitive inflammation and tissue fibrosis.
    Artunc F; Lang F
    Nephron Physiol; 2014; 128(1-2):35-9. PubMed ID: 25377230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced blood pressure sensitivity to deoxycorticosterone in mice with disruption of bradykinin B2 receptor gene.
    Emanueli C; Fink E; Milia AF; Salis MB; Conti M; Demontis MP; Madeddu P
    Hypertension; 1998 Jun; 31(6):1278-83. PubMed ID: 9622142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and implications of new types of mineralocorticoid hypertension.
    Biglieri EG; Irony I; Kater CE
    J Steroid Biochem; 1989 Jan; 32(1B):199-204. PubMed ID: 2913410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The hypertensive role of corticosteroids in the light of adenoma of the adrenal cortex].
    Gláz E
    Orv Hetil; 1989 May; 130(22):1139-44, 1147-51. PubMed ID: 2668840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.